Workflow
nanOss Strata™
icon
Search documents
Xtant Medical Finalizes Companion Spine Transactions
Prnewswire· 2026-03-02 13:00
Core Viewpoint - Xtant Medical has finalized transactions with Companion Spine, receiving a total of $10.7 million, which completes the sale of its Coflex® assets and Paradigm OUS businesses for an aggregate price of $21.4 million [1] Financial Summary - The recent payment of $10.7 million includes $8.2 million for the satisfaction of an unsecured promissory note and $2.2 million for working capital and other purchase price adjustments [1] - The total purchase price for the divestitures amounts to $21.4 million [1] Strategic Focus - The completion of these transactions allows Xtant Medical to concentrate on its higher-margin biologics business while placing its assets with a recognized leader in the neuro-musculoskeletal space [1] - The additional funds from the transaction will enable the company to reduce long-term debt and enhance cash liquidity [1] Company Overview - Xtant Medical Holdings, Inc. is a global medical technology company focused on surgical solutions for spinal and orthopedic conditions, emphasizing the design, development, and commercialization of orthobiologics [1]
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
Prnewswire· 2025-12-11 13:00
Core Viewpoint - Xtant Medical Holdings, Inc. has launched its next-generation synthetic bone graft, nanOss Strata, aimed at improving surgical outcomes for spinal and orthopedic conditions [1][4]. Product Details - nanOss Strata is made from hydroxycarbonapatite (HCA), which has higher solubility than traditional hydroxyapatite (HA), enhancing bioactivity and integration with surrounding bone tissue [2]. - The product features a nanocrystalline structure that mimics human bone, increasing surface area for better osteoconductivity and cellular activity stimulation post-implantation [2]. - Strata is available in two forms: compression-resistant preformed strips and prehydrated moldable grafts, both of which are sterile and absorb biologic fluids quickly [3]. Company Commitment - The CEO of Xtant Medical emphasized the company's dedication to innovation in regenerative medicine and improving surgical outcomes through the introduction of nanOss Strata [4]. - Xtant Medical operates a nationwide distribution network to make nanOss Strata accessible to surgeons [4]. Company Overview - Xtant Medical Holdings, Inc. focuses on the design, development, and commercialization of orthobiologics for chronic and surgical wound care, sports medicine, and spinal implant systems [5].